ACUVUE® OASYS Brand family of 2-week reusable contact lenses has never been beaten in comfort in 22 clinical studies posted on ClinicalTrials.gov.^
ACUVUE® OASYS 2-WEEK for ASTIGMATISM are part of the ACUVUE® OASYS family that is the #1 selling contact lens brand in the world.*
ACUVUE® Brand Contact Lenses for ASTIGMATISM with EYELID STABILISED DESIGN are designed to keep vision more stable during many of life’s activities.1
ACUVUE® OASYS 2-WEEK for ASTIGMATISM blocks approximately 96.1% of UVA rays and greater than 99.9% of UVB rays.3†
ACUVUE® RevitaLens Multi-Purpose Disinfecting Solution, is a great match with ACUVUE Contact Lenses and other leading brands.5,6,7 – it’s a tried and tested combination you and your patients can rely on6,8,9 for exceptional disinfection5,6,7 and all-day comfort.10
6 pack for 3 month's wear
| Title | Description |
|---|---|
Lens Material | Senofilcon A |
Technology | HYDRACLEAR® PLUS Technology |
Dk/t (edge-corrected)3◊ | 129X10-9 |
Water content | 38% |
Class 1 UV blocker†3 | >99.9% UVB, 96.1% UVA rays |
Center thickness at -3.00D | 0.080mm |
Base Curve | 8.6mm |
Diameter | 14.5mm |
Power Range | Plano to -6.00D (0.25D steps)
|
Visibility Tint | Yes |
Pack size | 6 lens pack |
EYELID STABILISED DESIGN is based on a four-zone stability system that utilises positive eyelid interaction by harnessing the power of the eye blink.1
Packing solution contains boric acid and disodium tetraborate (sodium borate) to control the pH of the solution.
*Source Euromonitor International Limited; Eyewear 2025 edition; value sales at rsp, all retail channels, 2023 data.
‡www.clinicaltrials.gov is a website maintained by the NIH. Since February 2007, 29 clinical studies evaluated subjective comfort as a primary or secondary endpoint for ACUVUE® OASYS Brand families of contact lenses vs. competitors’ products. Review conducted as of April 30, 2024.
†All ACUVUE® contact lenses have Class 1 or Class 2 UV-blocking to help provide protection against transmission of harmful UV radiation to the cornea and into the eye. UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. UV transmission measured with -1.00 lens.
^ClinicalTrials.gov is a website maintained by the NIH. The 22 clinical studies evaluated subjective comfort as a primary or secondary endpoint for ACUVUE® OASYS Brand 2-week family contact lenses vs. competitors’ products. Review conducted as of April 30, 2024.
◊Oxygen is only one of several factors related to maintaining overall eye health when wearing contact lenses.
REFERENCES
1. JJV Data on File 2024, ACUVUE® Brand Contact Lenses for ASTIGMATISM overall fitting success, orientation position, rotational stability and vision performance.
2. JJV Data on file October 2023. Proportion astigmats accommodated with ACUVUE® Brand CLs for ASTIGMATISM.
3. JJV Data on File 2019. Material Properties for Reusable Toric Contact Lenses, Including ACUVUE® OASYS Brand Contact Lenses for ASTIGMATISM and ACUVUE® VITA Brand Contact Lenses for ASTIGMATISM.
4. JJV Data on File 2018. Similarities between Mucin and Poly(N-Vinyl Pyrrolidone) (PVP).
5. Berntsen DA, Hickson-Curran SB, Jones LW, et al. Subjective Comfort and Physiology with Modern Contact Lens Care Products. Optom Vis Sci. 2016,93(8):809-819.
6. JJV Data on File 2017. Multi-center 1-month dispensing daily wear study with senofilcon C toric contact lenses with RevitaLens OcuTec MPDS, worn for 30 days, n=130 habitual soft toric contact lens wearers in US.
7. JJV Data on File 2016. Multi-center 1-month dispensing daily wear study with comfilcon A toric using RevitaLens OcuTec MPDS, n=95 habitual soft toric contact lens wearers in the US.
8. JJV Data on File 2017. RevitaLens OcuTec MPDS compatibility and clinical performance with ACUVUE® Brand Contact Lenses (2-week daily wear study with senofilcon A, etafilcon A & galyfilcon A, n=203 habitual soft contact lens wearers; 1-month daily wear study with senofilcon C toric contact lenses, N=130 habitual soft toric contact lens wearers, in-vitro laboratory evaluations with ACUVUE® Brand reusable contact lens materials).
9. JJV Data on File 2012-2015. Laboratory evaluations with RevitaLens OcuTec MPDS and reusable contact lens materials (senofilcon A, senofilcon C, etafilcon A & galyfilcon A).
10. JJV Data on File 2018. ACUVUE® RevitaLens Multipurpose Disinfecting Solution Packaging Claims
IMPORTANT SAFETY INFORMATION
ACUVUE® Contact Lenses are indicated for vision correction. As with any contact lenses, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. Contact lenses should not be used in case of eye infections or any other eye conditions, or in case of a systemic disease that may affect the eye. For detailed product information, including contraindications, precautions and adverse reactions, please consult the Instructions for Use available on the Johnson & Johnson website www.e-IFU.com
ACUVUE®, ACUVUE® OASYS, HYDRACLEAR® PLUS, ACUVUE® VITA and ACUVUE® RevitaLens are registered trademarks of Johnson & Johnson. © Johnson & Johnson and its affiliates 2024
2024PP16567
